Albert H. Chen

Statistics

Publications

Citations

285

H-Index

Active since

2008

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Albert H. Chen is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, oncogenic signaling pathways, and cancer pharmacology.

Publications per year

2008–2010

Publications

Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors

Jannik N. Andersen, Sriram Sathyanarayanan, Alessandra Di Bacco et al. · Science Translational Medicine · 2010 · 162 citations

Medicine, Oncology, Pharmacology +16

Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells

Kumiko Nagashima, Stuart D. Shumway, Sriram Sathyanarayanan et al. · Journal of Biological Chemistry · 2010 · 66 citations · Full text

Medicine, Oncology, Pharmacology +13

Modulation of peripheral B cell tolerance by CD72 in a murine model

Daniel Hsieh‐Hsin Li, Monte M. Winslow, Thai M. Cao et al. · Arthritis & Rheumatism · 2008 · 57 citations · Full text

Life Sciences, Immunology, Pathology +17

1–3 of 3